Felix Porras
Longevity Medical Institute, San José del Cabo, Baja California Sur, Mexico, Longevity Medical Institute, Houston, TX, United States
Publications
-
Research Article
Intradiscal Mesenchymal Stromal/Stem Cell Therapy for Lumbar Discogenic Low Back Pain Due to Degenerative Disc Disease: A Systematic Review
Author(s): Kirk Sanford*, Felix Porras, Fergie Martinez, Hugo Ramos, Janine Zamitiz, Carlos Green and Edward Ramsay
Background Degenerative disc disease is a major contributor to chronic low back pain and disability worldwide. Conventional treatments, including physical therapy, pharmacologic management, and surgical interventions, often focus on symptom control rather than addressing the underlying biological degeneration of the intervertebral disc. Intradiscal mesenchymal stromal/stem cell therapy has emerged as a regenerative medicine approach aimed at modulating inflammation, restoring disc homeostasis, and improving clinical outcomes in patients with discogenic low back pain. Objective To evaluate the efficacy and safety of intradiscal mesenchymal stromal/stem cell therapy in adults with lumbar degenerative disc disease and discogenic low back pain. Methods A systematic review of human clinical studies was conducted followi.. Read More»